Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Open accessThe DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
SUMMARY: Treatment of infectious diseases becomes more challenging with each passing year. This is especially true for infections caused by the opportunistic pathogen Pseudomonas aeruginosa, with its ability to rapidly develop resistance to multiple classes of antibiotics. Although the import of resistance mechanisms on mobile genetic elements is always a concern, the most difficult challenge we face with P. aeruginosa is its ability to rapidly develop resistance during the course of treating an infection. The chromosomally encoded AmpC cephalosporinase, the outer membrane porin OprD, and the multidrug efflux pumps are particularly relevant to this therapeutic challenge. The discussion presented in this review highlights the clinical significance of these chromosomally encoded resistance mechanisms, as well as the complex mechanisms/pathways by which P. aeruginosa regulates their expression. Although a great deal of knowledge has been gained toward understanding the regulation of AmpC, OprD, and efflux pumps in P. aeruginosa, it is clear that we have much to learn about how this resourceful pathogen coregulates different resistance mechanisms to overcome the antibacterial challenges it faces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–207 of 207
Chuanchuen, R., Gaynor, J. B., Karkhoff-Schweizer, R. R., & Schweizer, H. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1844-1851.2005 · Cited by 36
Failure of Therapy in Pseudomonas Endocarditis: Selection of Resistant Mutants
Jimenez-Lucho, V. E., Saravolatz, L. D., Medeiros, A. A., & Pohlod, D. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.1.64 · Cited by 36
Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa
Margaret, B. S., Drusano, G. L., & Standiford, H. C. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.suppl_a.161 · Cited by 31
Bishop, R. E., & Weiner, J. H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17775.x · Cited by 21
Villavicencio, R. T. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00137-9 · Cited by 20
Labia, R., Morand, A., & Péduzzi, J. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/17.suppl_c.17 · Cited by 17
Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia
Tam, V. H., Chang, K., Schilling, A. N., LaRocco, M., Genty, L. O., & Garey, K. W. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.11.007 · Cited by 17
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
Pseudomonas genomes: diverse and adaptable
Silby, M. W., Winstanley, C., Godfrey, S. A. C., Levy, S. B., & Jackson, R. W. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00269.x · Cited by 960
Metadata
- Authors
- Lister, P. D., Wolter, D. J., & Hanson, N. D.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2009-10
- Volume
- 22
- Issue
- 4
- Pages
- 582-610
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2075287054
- Cited by
- 1,789
- References
- 207
- FWCI
- 19.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.